Financials IMPACT Therapeutics, Inc

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2026-07-24 EDT			5-day change	1st Jan Change
11.50 ^HKD	-4.64%		-17.92%	-

07-20	Impact Therapeutics Announces Clinical Data for Senaparib, IMP4297, and IMP1707 Accepted for Poster Presentation at 2026 ESMO Congress	CI
06-07	Impact Therapeutics Nets HK$120 Million From Full Exercise of IPO Overallotment Option	MT

Fiscal Period: December	2026	2027	2028
Net sales ¹	277.5	941.3	763.9
Change	-	239.15%	-18.85%
EBITDA ¹	-140.6	424.5	124.9
Change	-	401.96%	-70.57%
EBIT ¹	-143.2	421.3	121.2
Change	-	394.13%	-71.24%
Interest Paid	-	-	-
Earnings before Tax (EBT)	-	-	-
Change	-	-	-
Net income	-	-	-
Change	-	-	-
Announcement Date	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2026	2027	2028
Net Debt ¹	-832	-1,277	-1,456
Change	-	-53.49%	-14.02%
Announcement Date	-	-	-

¹CNY in Million

Estimates

¹CNY in Million

Estimates

Fiscal Period: December	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-	-50.65%	45.1%	16.35%
EBIT Margin (%)	-	-	-51.61%	44.76%	15.86%
EBT Margin (%)	-	-	-	-	-
Net margin (%)	-	-	-	-	-
FCF margin (%)	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-
Profitability
ROA	-	-40.35%	-	-	-
ROE	-	34.77%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-
Items per share
Cash flow per share ¹	1.148	1.104	-	-	-
Change	-	-3.81%	-	-	-
Dividend per Share ¹	-	-	-	-	-
Change	-	-	-	-	-
Book Value Per Share ¹	-3.712	-4.09	-	-	-
Change	-	-10.19%	-	-	-
EPS ¹	-1.271	-1.295	-	-	-
Change	-	-1.91%	-	-	-
Nbr of stocks (in thousands)	-	-	-	-	-
Announcement Date	5/5/26	5/5/26	-	-	-